Searle & Co. Johnson & Johnson Transaction History

Searle & Co.

$390 Million
Q1 2024

A detailed history of Searle & Co. transactions in Johnson & Johnson stock. As of the latest transaction made, Searle & Co. holds 40,962 shares of JNJ stock, worth $5.97 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares

40,962

Previous 40,462 1.24%

Holding current value

$5.97 Million

Previous $6.34 Million 2.16%

% of portfolio

1.66%

Previous 1.75%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$155.22 - $162.74 $77,610 - $81,370	500 Added 1.24%	40,962 $6.48 Million
Q4 2023 Feb 05, 2024	BUY	$145.6 - $158.88 $18,345 - $20,018	126 Added 0.31%	40,462 $6.34 Million
Q2 2023 Aug 11, 2023	BUY	$154.35 - $166.11 $51,707 - $55,646	335 Added 0.84%	40,336 $6.68 Million
Q1 2023 Jun 01, 2023	SELL	$151.05 - $180.26 $124,465 - $148,534	-824 Reduced 2.02%	40,001 $6.2 Million
Q2 2022 Aug 03, 2022	BUY	$168.19 - $186.01 $504,570 - $558,030	3,000 Added 7.93%	40,825 $7.25 Million

Q1 2020 May 12, 2020	SELL	$111.14 - $153.99 $66,684 - $92,394	-600 Reduced 1.56%	37,825 $4.96 Million
Q4 2019 Jan 21, 2020	SELL	$127.5 - $146.44 $10,837 - $12,447	-85 Reduced 0.22%	38,425 $5.61 Million
Q2 2019 Jul 17, 2019	BUY	$131.15 - $144.24 $52,460 - $57,696	400 Added 1.05%	38,510 $5.36 Million
Q1 2019 Apr 22, 2019	BUY	$125.72 - $139.79 $30,172 - $33,549	240 Added 0.63%	38,110 $5.33 Million
Q4 2018 Feb 12, 2019	SELL	$122.84 - $147.84 $331,668 - $399,168	-2,700 Reduced 6.66%	37,870 $4.89 Million
Q4 2017 Jan 17, 2018	BUY	$131.22 - $143.62 $31,755 - $34,756	242 Added 0.6%	40,570 $5.67 Million
Q3 2017 Oct 27, 2017	BUY	$129.47 - $135.38 $5.22 Million - $5.46 Million	40,328	40,328 $5.24 Million

Others Institutions Holding JNJ

# of Institutions

4,147

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

News

Stay updated on Searle & Co. with notifications on news.

Account